By Dan Prochilo ( July 30, 2013, 7:00 PM EDT) -- A New York federal judge Monday denied generic-drug maker Akorn Inc.'s argument that a $100 million trade secrets and breach of contract suit filed by Fera Pharmaceuticals LLC was barred by the companies' supply agreement, ruling the agreement might have been induced by fraud, and therefore invalid....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.